L4-2286 — Final report
1.
Protein nanoparticles containing TNF- [alpha] analogs and their use in anti-cancer and anti-TNF therapy

On the conference, which gathered the key researchers working in the field of TNF and other cytokines, we presented the results of the project in oral presentation and poster, with the emphasis on TNF-based nanoparticle preparation and its use in biomedical applications.

B.03 Paper at an international scientific conference

COBISS.SI-ID: 4688922
2.
Protein nanoparticles containing TNF-[alpha] analogs and their use in anti-cancer and anti-TNF therapy

On the local conference we presented our results in the form of poster presentation and in this way informed the Slovenian scientific community. We presented TNF-based nanoparticles and their use in anti-TNF therapy and in anti-cancer therapy.

B.06 Other

COBISS.SI-ID: 4823834
3.
Histidine residues as a tool for protein nanoparticle formation - invited lecture

Invited lecture at the international conference EuroNanoMedicine - HRIBAR, Gorazd, ŽNIDARŠIČ, Andrej, BELE, Marjan, CASERMAN, Simon, SMILOVIĆ, Vanja, VENTURINI, Peter, GABERC-POREKAR, Vladka. Histidine residues as a tool for protein nanoparticle formation. V: EuroNanoMedicine 2009, September 28-30, 2009, Bled, Slovenia. Book of abstracts incl. programme. [S. l.: s. n., 2009], str. 32.

B.04 Guest lecture

COBISS.SI-ID: 4283162
4.
Controlled aggregation of tumor necrosis factor alpha analogs into protein nanostructures

Doctoral thesis entitled ''Controlled aggregation of tumor necrosis factor alpha analogs into protein nanostructures'' describes novel approaches how to prepare protein nanoparticles capable of controlled release of active molecules in vivo.

D.09 Tutoring for postgraduate students

COBISS.SI-ID: 248819200
5.
Protein nanoparticles containing TNF- [alfa] analogs and their use in anti-cancer and anti-TNF therapy

On the conference, which gathered the key researchers working in the field of cytokines, we presented the results of the project and our contribution to the field of novel TNF-based therapeutics.

B.03 Paper at an international scientific conference

COBISS.SI-ID: 4615962